BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 12607595)

  • 1. Expression of vascular endothelial growth factor in invasive ductal carcinoma of the breast and the relation to angiogenesis and p53 and HER-2/neu protein expression.
    Lee JS; Kim HS; Jung JJ; Kim YB; Lee MC; Park CS
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):289-95. PubMed ID: 12607595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma.
    Chhieng DC; Tabbara SO; Marley EF; Talley LI; Frost AR
    Breast J; 2003; 9(3):200-7. PubMed ID: 12752628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.
    Bos R; Zhong H; Hanrahan CF; Mommers EC; Semenza GL; Pinedo HM; Abeloff MD; Simons JW; van Diest PJ; van der Wall E
    J Natl Cancer Inst; 2001 Feb; 93(4):309-14. PubMed ID: 11181778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor.
    Callagy G; Dimitriadis E; Harmey J; Bouchier-Hayes D; Leader M; Kay E
    Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):104-9. PubMed ID: 10937057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH; Dublin EA; Bobrow LG; Poulsom R
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma.
    Valković T; Dobrila F; Melato M; Sasso F; Rizzardi C; Jonjić N
    Virchows Arch; 2002 Jun; 440(6):583-8. PubMed ID: 12070596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers.
    Hieken TJ; Farolan M; D'Alessandro S; Velasco JM
    Surgery; 2001 Oct; 130(4):593-600; discussion 600-1. PubMed ID: 11602889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression.
    Lee JS; Kim HS; Jung JJ; Lee MC; Park CS
    Gynecol Oncol; 2002 Jun; 85(3):469-75. PubMed ID: 12051876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation.
    Nakopoulou L; Stefanaki K; Panayotopoulou E; Giannopoulou I; Athanassiadou P; Gakiopoulou-Givalou H; Louvrou A
    Hum Pathol; 2002 Sep; 33(9):863-70. PubMed ID: 12378509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases.
    Kern A; Taubert H; Scheele J; Rudroff C; Mothes H; Kappler M; Bartel F; Richter KK
    Int J Oncol; 2002 Aug; 21(2):243-9. PubMed ID: 12118317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma.
    Linderholm B; Lindh B; Tavelin B; Grankvist K; Henriksson R
    Int J Cancer; 2000 Jan; 89(1):51-62. PubMed ID: 10719731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
    Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
    Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
    Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher plasma vascular endothelial growth factor levels correlate with menopause, overexpression of p53, and recurrence of breast cancer.
    Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Yamashita H; Fukuda M
    Breast Cancer; 2003; 10(2):120-8. PubMed ID: 12736564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast.
    Guidi AJ; Schnitt SJ; Fischer L; Tognazzi K; Harris JR; Dvorak HF; Brown LF
    Cancer; 1997 Nov; 80(10):1945-53. PubMed ID: 9366297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
    Perrone G; Santini D; Vincenzi B; Zagami M; La Cesa A; Bianchi A; Altomare V; Primavera A; Battista C; Vetrani A; Tonini G; Rabitti C
    Histopathology; 2005 May; 46(5):561-8. PubMed ID: 15842638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
    Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC
    Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression.
    Lee JS; Kim HS; Jung JJ; Park CS; Lee MC
    J Surg Oncol; 2001 May; 77(1):55-60. PubMed ID: 11344484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.